Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-IRBESARTAN HCTZ 12.5MG 300MG TABLET Resolved 2018-12-04 2019-04-11 68622
TEVA-IRBESARTAN HCTZ 12.5MG 150MG TABLET Resolved 2019-12-19 2021-09-10 101725
TEVA-IRBESARTAN HCTZ 12.5MG 150MG TABLET Resolved 2019-07-02 2019-11-01 88174
TEVA-IRBESARTAN HCTZ 12.5MG 150MG TABLET Resolved 2018-12-04 2019-04-11 68619
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Actual shortage 2025-10-30 2026-02-26 270666
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2021-01-07 2021-03-25 131087
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-08 2023-07-06 194119
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-16 2023-08-04 195033
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-19 2023-07-14 195597
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2025-12-04 2026-01-29 273296

Showing 651 to 660 of 765

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769

Showing 21 to 30 of 116